Navigation Links
Research identifies in-flight emergencies
Date:1/23/2009

do note that not all of the airlines had defibrillators as part of their medical flight kits. Sand said, "Considering the fact that cardiac conditions were the third most common condition seen in this study, patients with cardiac irregularities may profit from an on-board automatic external defibrillator. The same is true for patients with a suspected myocardial infarction."


'/>"/>

Contact: Graeme Baldwin
graeme.baldwin@biomedcentral.com
44-020-707-94804
BioMed Central
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Oklahoma State University researchers make breakthrough against poxviruses
2. HIPAA Privacy Rule Limits Americas Promise in Research
3. President Obama Gives the Unborn at Least a 24 Hour Reprieve, Postpones $441 Million Bailout of International Abortions, Says Family Research Council
4. Living with females extends the reproductive life of the male mouse, says Penn veterinary researcher
5. Upcoming Packard/Stanford Autism Symposium a Catalyst for Collaboration among Researchers and Community
6. UT Southwestern researchers find drug-coated stents less risky for heart bypass patients
7. MSU researcher receives $1.5 million grant for childhood obesity intervention study
8. Dana-Farber Cancer Institute Chooses MicroStrategy for Clinical Operations and Clinical Research Reporting Applications
9. American Heart Association 2008 Wrap-Up Report: Top Research Advances Include Studies That Influence Medical Care, Apply Science To Real World Communities
10. Photos: Apples iPhone Finds New Use in Treating Stuttering at Hollins Communications Research Institute
11. Horphag Research Receives 2008 Frost & Sullivan North American Health Ingredients Excellence In Research Award

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...at colorectal cancer also can reverse a rare stoma...erapy for the disease, researchers at Vanderbilt U...ier,s disease causes thickening of the stomach lin...s well as anemia and swelling in the feet and ankl...risk for gastric cancer. Previously, the only effe...
(Date:11/25/2009)...d under the skin kill tumor cells, study finds , ...A cancer vaccine delivered in a fingernail-size im...udy reports. , The method uses polymer disks, 8...umor-specific antigens and implanted under the ski... The Harvard University scientists who developed t...
(Date:11/25/2009)... Nationwide Imaging Services, known as one of...iagnostic imaging equipment, now offering a total ...cing options, service and installation with acquis...echnologies of California) , ...ide Imaging Services is proud to announce its acqu...
(Date:11/25/2009)... BioSpace.com, the premier resource for life ...d edition of the BioForest™ Hotbed Campaign ..., CO (Vocus) November 25, 2009 -- BioSpace.com, th...formation, unveiled the third edition of the BioFo...,This regional campaign is a promotional effort hi...
(Date:11/25/2009)...ethertoShareRecordsSafely,ImproveCare ,, WASH...tofVeteransAffairs(VA)andKaiserPermanentetodayanno...icestoourNation,sheroes.VAandKaiserPermanentearela...rd(EHR)informationusingtheNationwideHealthInformat...umanServices. ,, "Theabilitytosharecriticalheal...
Breaking Medicine News(10 mins):Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2Health News:VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program 2
... was warned about the rising number of Internet ga... Jan Wise, from London at the association's annual... implemented to track down and help addicts. Both ...to 15 year-olds show signs of addiction and 75 % a...
...titute of Health and Welfare (AIHW) it is found th...ber of negligence claims//. A new report show...epartment. Data was collected from 2002 when the m...octors were threatening to quit their jobs. T...
...oiding house dust mite allergens from the time of ...ema or atopy in high-risk children. Furthermore... of fish rich in omega-3 fatty acids was also foun...umption of omega-3 fatty acids, which are found in...
...ould help people lose weight, will be launched in ...ht loss preparation that controls //the desire to ... patients will be the first ones worldwide to have...essing the appetite. It is the first drug of its k...
...ndia by the George Institute for International Hea...dia were at a higher risk of developing lifestyle .... In a developing area of Andhra Pradesh, abou... studies have highlighted the escalating problem o...
...hat the insurance industry is unfair in dealing wi...g denied// travel insurance or are being asked to ...are disease free. A survey conducted by the ...th a pre-existing condition is treated the same. ...
Other Medicine News:Health News:Preventive Measures Proved Ineffective in Allergic Children 2Health News:Wonder Drug For Weight Loss Launched In UK 2Health News:Alarming Rise of Diabetes in Rural India - Survey Reports 2
(Date:11/25/2009)...RNewswire/--TheFDAgrantedtraditionalapprovalforINT...ersetranscriptaseinhibitor(NNRTI).INTELENCEistheon...riencedadultswhoareexperiencingvirologicfailurewit...ral(ARV)agents.Thetraditionalapprovalisbasedon48-w...INTELENCEiscurrentlymarketedintheU.S.byTibotecTher...
(Date:11/25/2009)...Newswire-USNewswire/--RemediumTechnologiesInc.,aco...rebleeding,wonfirstprizeand$10,000intheMostPromisi...2009,companyofficialsannouncetoday. ,, Selected...steampitchedtheirinventionattheGSCSecuritySummitco...edium( www.remediumtechnologies.com )isdevelopinga...
(Date:11/25/2009)...PRNewswire/--RegadoBiosciences,aprivatelyheldcompa...hactivecontrolagents,announcedthatDavidMazzo,PhD,C...stAnnualHealthCareConferenceattheNewYorkPalaceHote...1:10pm(EST)onTuesday,December1andwillincludeanover...elopmentprogram,theanticoagulantsystem,REG1.Thehea...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2New Compact and Folding Reading Glasses from VisAcuity com 3A Never Leave Home Without Them 47465 1New Compact and Folding Reading Glasses from VisAcuity com 3A Never Leave Home Without Them 47465 2Cyberonics Announces Exclusive Distribution Agreement With Nihon Kohden in Japan 47462 1Cyberonics Announces Exclusive Distribution Agreement With Nihon Kohden in Japan 47462 2Cyberonics Announces Exclusive Distribution Agreement With Nihon Kohden in Japan 47462 3Cyberonics Announces Exclusive Distribution Agreement With Nihon Kohden in Japan 47462 4PLUS Diagnostics First National Laboratory to Offer Highly Specialized Gastrointestinal Tests 47459 1PLUS Diagnostics First National Laboratory to Offer Highly Specialized Gastrointestinal Tests 47459 2
...d at 2008 ICAAC/IDSA Joint Meeting, ROCKVILLE, Md...armaceutical company focused on commercializing,pr...tential, announces the,successful demonstration of... inhibitory concentration (MIC) resulting from in ... candidate, SQ109, and Tibotec,s lead TB,drug cand...
...rmAthene, Inc.,(NYSE ALTERNEXT US: PIP), a biodefe...inst biological and chemical threats, today announ...Phase I clinical trial,evaluating Protexia(R) for ...ch is produced in the milk of transgenic goats, is...ase (BChE), which has been shown to be effective,i...
Other Medicine Technology:Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207 2PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R) 2PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R) 3PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R) 4PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R) 5
Neumann Tying Forceps - Straight
Neumann Tying Forceps - Angled
Shepard Straight Tying Forceps
Shepard Curved Tying Forceps
Medicine Products: